The U.S. Food and Drug Administration (FDA) Wants to Hear From Afib Patients
March 6, 2017
- Summary: FDA wants to hear from afib patients about their experiences being diagnosed and treated
- Reading time: 1-2 minutes
The FDA is holding Listening Sessions in order to learn more from those with atrial fibrillation. These will be held by the FDA’s Center for Devices and Radiological Health. This is the part of the FDA involved in approving and regulating devices used in treating afib.
For these listening sessions, they are looking for anyone with afib to share your experiences being diagnosed and treated with medications and/or procedures. They also want to understand how you made your procedure decisions and what impact your treatments have had on your quality of life. They will provide you with the questions beforehand so you can come prepared.
These one-hour small group teleconferences will take place on the following dates and times and will be filled on a first-come first-served basis (US patients only):
- Monday, March 13th 2:00 PM ET
(1 CT/12 MT/11 PT) - Wednesday, March 15th 2:00 PM ET
(1 CT/12 MT/11 PT) - Wednesday, March 29th 2:00 PM ET
(1 CT/12 MT/11 PT)
If you are interested and willing to participate, please email [email protected] to the attention of Andrea Furia-Helms.